Moderna, Inc.
General Information
Identification Code: 011080341579-06
Website: [object Object]
Entity Form: plc
Registration Category: Companies & groups
Registration Date: 2/24/2021
Last Update: 3/14/2024
EP Accredited Number: 2
Mission & Interests
Goals: Moderna’s mRNA technology quickly enabled us to pivot when the COVID-19 crisis emerged and to manufacture and deliver a safe, effective vaccine against COVID-19. In this context, Moderna concluded advance purchase agreements (APA) and contracts with the European Commission. Building on its mRNA platform, Moderna is also developing mRNA vaccines and therapies against other infectious diseases, and non-infectious diseases in oncology, rare diseases and other areas.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Competition
- Environment
- Institutional affairs
- International co-operation and development
- Justice and fundamental rights
- Public health
- Research and innovation
Levels of Interest:
- global
- national
- european
Activities
Main EU Legislative Proposals: EU Vaccines Strategy
European Health Emergency preparedness and Response Authority (HERA) & biopreparedness
Covid 19 vaccines policies & procurement mechanisms
Pharmaceutical Strategy for Europe
Revision of the EU general pharmaceuticals legislation
COVI Report on COVID-19 pandemic
Health technology assessment - joint clinical assessments of medicinal products
Communication Activities: Outreach emails to communicate Moderna announcements
Sponsored article in Politico on the mRNA technology and Moderna global health strategy
Science Business Roundtable (participation of officials from European Commission and members of EMA) – 27 April
Article for European Files Magazine (July edition)
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 200 Technology Square
Post Code: 02139
City: Cambridge
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: 200 Technology Square
Post Code: 02139
City: Cambridge
Country: UNITED STATES
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: The estimate of annual costs related to activities covered by the register includes personal costs, the relevant percentage of trade associations membership fees and relevant costs for intermediaries, as declared above.
Membership Information
Members10 Percent: 1
Members25 Percent: 2
Members50 Percent: 0
Members75 Percent: 0
Members: 3
Members F T E: 0.6000000238418579
Structure
Structure Type: Structure
Is Member Of: N/A
Organisation Members: VE - Vaccines Europe (https://www.vaccineseurope.eu)
Eucope - European Confederation of Pharmaceutical Entrepreneurs AISBL (www.eucope.org)
IFPMA - International Federation of PHarmaceutical Manufacturers & Associations (www.ifpma.org)
BIO - Biotechnology Innovation Organization (www.bio.org)